SelectQuote Q1 revenue fell to $280.0 million; net loss narrowed to $20.3 million
SelectQuote reported first-quarter fiscal 2027 results for the period ended September 30, 2026, with revenue down from $328.8 million a year earlier while its net loss and adjusted EBITDA improved. The company reiterated its full-year fiscal 2027 targets, including revenue of $1.35 billion to $1.45 billion and adjusted EBITDA of $90 million to $115 million. Shareholders get a mixed picture: the top line shrank, but the company is losing less money and has not changed its outlook.
Key points
- Revenue was $280.0 million, down from $328.8 million in the year-earlier quarter.
- Net loss was $20.3 million, compared with $30.5 million a year earlier; adjusted EBITDA was $(17.0) million, compared with $(32.1) million.
- Fiscal 2027 guidance was reiterated: revenue of $1.35 billion to $1.45 billion, adjusted EBITDA of $90 million to $115 million, and operating cash flow of more than $60 million.
- SelectRx members totaled 99,753 as of September 30, 2026, down 7% from 106,914 a year earlier.
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.